Literature DB >> 17916820

Familial hypercholesterolaemia: Cascade testing is tried and tested and cost effective.

Gaye S Hadfield, Steve E Humphries.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17916820      PMCID: PMC2001068          DOI: 10.1136/bmj.39353.483160.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Census of clinics providing specialist lipid services in the United Kingdom.

Authors:  D Marks; M Thorogood; J M Farrer; S E Humphries
Journal:  J Public Health (Oxf)       Date:  2004-12       Impact factor: 2.341

2.  Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.

Authors:  Dalya Marks; David Wonderling; Margaret Thorogood; Helen Lambert; Steve E Humphries; H Andrew W Neil
Journal:  BMJ       Date:  2002-06-01

3.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.

Authors:  D Bhatnagar; J Morgan; S Siddiq; M I Mackness; J P Miller; P N Durrington
Journal:  BMJ       Date:  2000-12-16

4.  Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre.

Authors:  J Gray; A Jaiyeola; M Whiting; M Modell; A S Wierzbicki
Journal:  Heart       Date:  2007-06-17       Impact factor: 5.994

5.  Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.

Authors:  David S Wald; Jonathan P Bestwick; Nicholas J Wald
Journal:  BMJ       Date:  2007-09-13
  5 in total
  3 in total

1.  Familial hypercholesterolaemia: screening needs a fresh approach.

Authors:  David S Wald; Jonathan P Bestwick; Nicholas J Wald
Journal:  BMJ       Date:  2007-11-17

2.  Cascade genetic testing for mismatch repair gene mutations.

Authors:  R J Mitchell; R K Ferguson; A Macdonald; M G Dunlop; H Campbell; M E Porteous
Journal:  Fam Cancer       Date:  2008-04-04       Impact factor: 2.375

Review 3.  Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.

Authors:  Teri A Manolio
Journal:  Atherosclerosis       Date:  2016-08-26       Impact factor: 5.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.